Hodgkin's lymphoma: the hazards of success

Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.

Leukemia & lymphoma·2023

Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada.

Leukemia & lymphoma·2023

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.

Blood·2023

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.

Blood·2022

The outcome of older adults with classic Hodgkin lymphoma in British Columbia.

Blood advances·2022

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.

The New England journal of medicine·2022

Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Recent Population-Level Trends in Utilization of Outpatient Medical Oncology Services.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Programmed Clonal Expansion Associated with V(D)J Recombination Drives an ATM-Dependent Vulnerability Underlying Preferential Lymphocyte Depletion and Myeloid Bias Following DNA Damage.

bioRxiv : the preprint server for biology·2026

Comparative evidence on the independent contribution of granulocyte-macrophage colony-stimulating factor to anti-GD2 immunotherapy in neuroblastoma: a systematic review and gap analysis.

Frontiers in oncology·2026

Complete Resection of a Giant Middle Mediastinal Castleman Disease Using Robot-Assisted Thoracic Surgery: A Case Report.

Surgical case reports·2026

Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation.

Journal of clinical pharmacology·2026

Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma.

Cancer medicine·2026

Mucosal Melanoma: Clinical and Biological Implications of Anatomic Site.

Pigment cell & melanoma research·2026

Related Experiment Videos

Hodgkin's lymphoma: the hazards of success

Related Concept Videos

Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.

Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada.

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.

The outcome of older adults with classic Hodgkin lymphoma in British Columbia.

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.

Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer Care.

Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness Trial.

Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.

Recent Population-Level Trends in Utilization of Outpatient Medical Oncology Services.

Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study.

P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.

Programmed Clonal Expansion Associated with V(D)J Recombination Drives an ATM-Dependent Vulnerability Underlying Preferential Lymphocyte Depletion and Myeloid Bias Following DNA Damage.

Comparative evidence on the independent contribution of granulocyte-macrophage colony-stimulating factor to anti-GD2 immunotherapy in neuroblastoma: a systematic review and gap analysis.

Complete Resection of a Giant Middle Mediastinal Castleman Disease Using Robot-Assisted Thoracic Surgery: A Case Report.

Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation.

Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma.

Mucosal Melanoma: Clinical and Biological Implications of Anatomic Site.

Related Experiment Videos

Hodgkin's lymphoma: the hazards of success

Related Concept Videos

Related Articles